Company Monitoring Page for Merck

latest headlines for company on cafepharma

With 9% pay hike, Merck CEO Robert Davis entered $20M compensation club in 2023
Fierce Pharma
Sun, 04/14/24 - 01:20 pm
Tags:
Merck, Pharma CEOs, Robert Davis, executive compensation
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wed, 04/10/24 - 09:59 am
Tags:
Merck, Kelun-Biotech, SKB264, gastric cancer, antibody-drug conjugate, clinical trials, AACR
Moderna jumps as vaccine shows benefit in head and neck cancer in early study
Reuters
Tue, 04/9/24 - 05:43 pm
Tags:
Moderna Therapeutics, Merck, clinical trials, vaccines, head and neck cancer
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
BioSpace
Fri, 04/5/24 - 11:42 am
Tags:
Merck, clinical trials, KRAS inhibitors, MK-1084, non-small lung cancer
Daiichi Sankyo and Merck dose first subject in ovarian cancer trial
Clinical Trials Arena
Thu, 04/4/24 - 10:53 am
Tags:
Daiichi Sankyo, Merck, ovarian cancer, clinical trials, raludotatug deruxtecan, R-DXd
'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns
Fierce Biotech
Wed, 04/3/24 - 10:30 pm
Tags:
Peter Marks, FDA, cancer vaccine, Moderna Therapeutics, Merck, MRNA, mRNA-4157
EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer
BioSpace
Thu, 03/28/24 - 04:56 pm
Tags:
Merck, Europe, Keytruda, non-small cell lung cancer
Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair
Fierce Pharma
Wed, 03/27/24 - 11:22 am
Tags:
Merck, FDA, PAH, Winrevair, sotatercept, Acceleron
Merck’s next big thing is (probably) on the way
Stat
Tue, 03/26/24 - 11:03 am
Tags:
Merck, FDA, sotatercept, PAH
Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology
BioSpace
Mon, 03/25/24 - 11:32 am
Tags:
Merck, Keytruda, immunotherapy, oncology, cancer
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma
Clinical Trials Arena
Thu, 03/21/24 - 06:41 pm
Tags:
bladder cancer, urothelial cancer, Merck, Pfizer, Bristol Myers Squibb, Padcev, Keytruda, Balversa, Opdivo
Merck combination treatment for lung cancer fails late-stage study
Reuters
Thu, 03/21/24 - 11:13 am
Tags:
Merck, Keytruda, Lynparza, AstraZeneca, non small cell lung cancer
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data
BioSpace
Fri, 03/15/24 - 11:28 am
Tags:
Merck, Keytruda, cervical cancer, clinical trials
Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office
Fierce Pharma
Thu, 03/14/24 - 11:29 am
Tags:
Merck, Johns Hopkins, Keytruda, patents
Merck to start trials investigating single dosing regiments of HPV vaccine
Clinical Trials Arena
Wed, 03/13/24 - 10:55 am
Tags:
Merck, HPV, vaccines, Gardasil 9, clinical trials
Merck bets up to $1B on Pearl's 'smart' biomaterial jewels as biotech begins to raise fresh funds
Fierce Biotech
Tue, 03/12/24 - 11:12 am
Tags:
Merck, Pearl Bio, cancer, biologics
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
Tags:
oncology, cancer, antibody-drug conjugate, Merck, AbbVie, Pfizer, AstraZeneca
Merck to open new distribution centre in Brazil for Life Science sector
Pharmaceutical Business Review
Wed, 02/28/24 - 10:30 am
Tags:
Merck, Brazil, distribution
Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
BioSpace
Tue, 02/27/24 - 10:18 am
Tags:
Merck, patents, Hikma, Bridion, muscle relaxants, generics
Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster
First Word Pharma
Thu, 02/22/24 - 11:43 am
Tags:
Samsung Bioepis, Merck, biosimilars, Keytruda, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.